These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4040217)

  • 1. Chlorimipramine, electroconvulsive shock and combination thereof: differential effects of chronic treatment on apomorphine-induced behaviours and on striatal and mesocortical dopamine turnover.
    Spyraki C; Papadopoulou Z; Kourkoubas A; Varonos D
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):128-34. PubMed ID: 4040217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chronic electroconvulsive shock on interstitial concentrations of dopamine in the nucleus accumbens.
    Nomikos GG; Zis AP; Damsma G; Fibiger HC
    Psychopharmacology (Berl); 1991; 105(2):230-8. PubMed ID: 1724565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal dopamine metabolism in response to apomorphine: the effects of repeated amphetamine pretreatment.
    Kuczenski R; Leith NJ; Applegate CD
    Brain Res; 1983 Jan; 258(2):333-7. PubMed ID: 6824917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the mechanism of mergocryptine-induced suppression of dopamine turnover in the rat striatum.
    Hashimoto T; Katsura M; Kuriyama K
    Eur J Pharmacol; 1991 Jun; 198(2-3):121-7. PubMed ID: 1864302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential responses in central dopaminergic activity induced by apomorphine in IPL nude rat.
    Estrella CR; Bregonzio C; Cabrera RJ
    Behav Brain Res; 2002 Jul; 133(2):143-8. PubMed ID: 12110447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential biochemical and behavioral effects of single and chronic administration of amphetamine and apomorphine.
    Bernardi MM; Scavone C
    Gen Pharmacol; 1985; 16(4):407-10. PubMed ID: 4043718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
    Zetterström T; Sharp T; Ungerstedt U
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):117-24. PubMed ID: 2946964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of drugs altering striatal dopamine levels on apomorphine induced stereotypy.
    Feigenbaum JJ; Yanai J; Blass RB; Moon B; Klawans H
    Pharmacol Biochem Behav; 1982 Feb; 16(2):235-40. PubMed ID: 7200236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the mechanism of potentiation of apomorphine-induced stereotypy due to electroconvulsive shock.
    Gulati A; Srimal RC; Dhawan KN; Dhawan BN
    Neuropharmacology; 1987 Dec; 26(12):1733-7. PubMed ID: 3437939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
    LaHoste GJ; Marshall JF
    Behav Brain Res; 1990 May; 38(3):233-42. PubMed ID: 1973041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS; Joyce JN
    Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of electroconvulsive shock seizures on behaviour induced by dopaminergic agonists and on immobility in the Porsolt test.
    Zarrindast MR; Sahebgharani M; Burnham WM
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):509-14. PubMed ID: 15589391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of behavioral evidence for dopamine autoreceptor subsensitivity after acute electroconvulsive shock.
    Creese I; Kuczenski R; Segal D
    Pharmacol Biochem Behav; 1982 Aug; 17(2):375-6. PubMed ID: 6291070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cortical ablation on apomorphine- and scopolamine-induced changes in dopamine turnover and ascorbic acid catabolism in the rat striatum.
    Desole MS; Miele M; Enrico P; Esposito G; Fresu L; De Natale G; Miele E
    Eur J Pharmacol; 1992 Aug; 219(1):67-74. PubMed ID: 1356809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
    Giambalvo CT; Snodgrass SR
    Brain Res; 1978 Sep; 152(3):555-66. PubMed ID: 308384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
    Nisoli E; Tonello C; Imhof R; Scherschlicht R; da Prada M; Carruba MO
    J Pharmacol Exp Ther; 1993 Jul; 266(1):97-105. PubMed ID: 8101225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat.
    Carter CJ; Pycock CJ
    Brain Res; 1980 Jun; 192(1):163-76. PubMed ID: 7189685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of changes in locomotor activity with striatal homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations following the bilateral intranigral injection of dopamine agonist drugs in rats.
    Kelly E; Jenner P; Marsden CD
    J Pharm Pharmacol; 1987 Mar; 39(3):196-202. PubMed ID: 2883284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated electroconvulsive shock prevents the sedative effect of small doses of apomorphine.
    Serra G; Argiolas A; Fadda F; Melis MR; Gessa GL
    Psychopharmacology (Berl); 1981; 73(2):194-6. PubMed ID: 6785815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subsensitivity to dopaminergic drugs in periadolescent rats: a behavioral and neurochemical analysis.
    Bolanos CA; Glatt SJ; Jackson D
    Brain Res Dev Brain Res; 1998 Nov; 111(1):25-33. PubMed ID: 9804875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.